Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression

CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

(2011) G. L. Beatty et al.   SCIENCE

Innate control of B cell responses

(2011) Andrea Cerutti et al.   TRENDS IN IMMUNOLOGY

The lymph node microenvironment promotes B-cell receptor signaling, NF- B activation, and tumor proliferation in chronic lymphocytic leukemia

(2010) Y. Herishanu et al.   BLOOD

A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154

(2010) W G Wierda et al.   LEUKEMIA

Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response

(2009) J Reay et al.   CANCER GENE THERAPY

Cancer-induced Expansion and Activation of CD11b+Gr-1+ Cells Predispose Mice to Adenoviral-triggered Anaphylactoid-type Reactions

(2009) Kalyan Pande et al.   MOLECULAR THERAPY

Induction of Shock After Intravenous Injection of Adenovirus Vectors: A Critical Role for Platelet-activating Factor

(2009) Zhili Xu et al.   MOLECULAR THERAPY

The role of CD40 and CD154/CD40L in dendritic cells

(2009) Daphne Y. Ma et al.   SEMINARS IN IMMUNOLOGY

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

(2008) M. Hallek et al.   BLOOD

Factors influencing retention of adenovirus within tumours following direct intratumoural injection

(2008) M Bazan-Peregrino et al.   GENE THERAPY

Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma

(2007) S Serba et al.   GUT